EyeGene Inc Asset Resilience Ratio

Latest as of March 2026: 53.36%

EyeGene Inc asset resilience ratio. EyeGene Inc (185490) has an Asset Resilience Ratio of 53.36% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can EyeGene Inc fund operations to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩34.53 Billion

≈ $23.40 Million USD Cash + Short-term Investments

Total Assets

₩64.70 Billion

≈ $43.85 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of EyeGene Inc (2014–2025)

Asset resilience ratio of EyeGene Inc from 2014 to 2025. This chart shows how EyeGene Inc's Asset Resilience Ratio has changed over time. Read EyeGene Inc (185490) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down EyeGene Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 185490 asset base.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩34.53 Billion	53.36%
Total Liquid Assets	₩34.53 Billion	53.36%

Asset Resilience Insights

Very High Liquidity: EyeGene Inc maintains exceptional liquid asset reserves at 53.36% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

EyeGene Inc Industry Peers by Asset Resilience Ratio

Compare EyeGene Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	Biotechnology	33.37%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Bavarian Nordic CO:BAVA	Biotechnology	10.83%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

EyeGene Inc Asset Resilience Ratio by Year (2014–2025)

EyeGene Inc asset resilience ratio by year from 2014 to 2025. The table below shows the annual Asset Resilience Ratio data for EyeGene Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	51.88%	₩35.30 Billion ≈ $23.92 Million	₩68.05 Billion ≈ $46.12 Million	+3.36pp
2024-12-31	48.52%	₩31.68 Billion ≈ $21.47 Million	₩65.31 Billion ≈ $44.26 Million	-20.07pp
2023-12-31	68.58%	₩53.56 Billion ≈ $36.30 Million	₩78.10 Billion ≈ $52.93 Million	-13.14pp
2022-12-31	81.72%	₩65.69 Billion ≈ $44.52 Million	₩80.38 Billion ≈ $54.47 Million	+1.19pp
2021-12-31	80.54%	₩84.56 Billion ≈ $57.30 Million	₩104.99 Billion ≈ $71.15 Million	+6.18pp
2020-12-31	74.36%	₩33.04 Billion ≈ $22.39 Million	₩44.43 Billion ≈ $30.11 Million	-4.20pp
2019-12-31	78.56%	₩37.17 Billion ≈ $25.19 Million	₩47.31 Billion ≈ $32.06 Million	-7.96pp
2018-12-31	86.52%	₩46.76 Billion ≈ $31.69 Million	₩54.04 Billion ≈ $36.62 Million	+10.89pp
2017-12-31	75.63%	₩22.90 Billion ≈ $15.52 Million	₩30.28 Billion ≈ $20.52 Million	+9.68pp
2016-12-31	65.95%	₩12.24 Billion ≈ $8.29 Million	₩18.56 Billion ≈ $12.58 Million	-5.66pp
2015-12-31	71.61%	₩17.42 Billion ≈ $11.81 Million	₩24.33 Billion ≈ $16.49 Million	+35.39pp
2014-12-31	36.23%	₩2.01 Billion ≈ $1.36 Million	₩5.54 Billion ≈ $3.76 Million	--

pp = percentage points

About EyeGene Inc

KQ:185490 Korea Biotechnology

Market Cap

$49.56 Million

₩73.13 Billion KRW

Market Cap Rank

#21748 Global

#1313 in Korea

Share Price

₩1692.00

Change (1 day)

-1.23%

52-Week Range

₩1193.00 - ₩2375.00

All Time High

₩50300.00